- Last updated
- October 16, 2024
- Terms of use
-
- Organization
- Swissmedic Swiss Agency for Therapeutic Products
Description
Pursuant to Art. 16 or the Epidemics Act (EpidA, SR 818.101), laboratories that perform microbiological analyses for the purpose of detecting or excluding transmissible diseases are required to hold an establishment license issued by Swissmedic.
Each year, the Swiss Agency for Therapeutic Products publishes a list of laboratories that have been licensed under Art. 22 of the Ordinance on microbiology laboratories (SR 818.101.32).
Following the entry into force of the new Therapeutic Products Act (TPA, SR 812.21) and the revised Medicinal Products Licensing Ordinance (MPLO, SR 812.212.1), establishment licenses for microbiology laboratories granted from 1st January 2019 have been issued under a new process. Holders of establishment licenses issued under the new process appear in the following list:
«Laboratory establishment licenses issued under the new process».
Resources
Showcases
Additional information
- Identifier
- bw204@swissmedic
- Issued date
- -
- Modified date
- October 16, 2024
- Conforms to
- -
- Publisher
- Schnittstellen-Team ‘Internet’
- Contact points
- Languages
- Language independent
- Further information
- PDF File zu diesen Daten
- Landing page
- https://www.swissmedic.ch/swissmedic/de/home/humanarzneimittel/bewilligungen_zertifikate/mikrobiologische-laboratorien/bewilligungsinhaber.html
- Documentation
- -
- Temporal coverage
- -
- Spatial coverage
- -
- Update interval
- Monthly
- Metadata Access
- API (JSON) Download XML
Got questions?
Ask the point of contact directly
Technischer Ansprechpartner (bitte im Vermerk angeben, dass es sich um die Schnittstelle bw204 handelt)
